Leadership Overview
Jubilant Pharmova has 7 executives leading key functions including operations, finance, marketing, human resources, and international business.
Driven by a patient-focused mission, Jubilant Pharmova is dedicated to advancing healthcare through innovative biopharmaceutical solutions and a commitment to global market impact.
Driven by a patient-focused mission, Jubilant Pharmova is dedicated to advancing healthcare through innovative biopharmaceutical solutions and a commitment to global market impact.
Leadership Roles at Jubilant Pharmova
Sanjay Bhartia - Chief Financial Officer
Sanjay Bhartia, the Chief Financial Officer at Jubilant Pharmova, manages the company's financial health and strategic fiscal planning. Bhartia oversees all financial operations, including accounting, budgeting, and financial reporting, ensuring robust fiscal discipline. This role is pivotal in guiding investment decisions and resource allocation to support the company's growth objectives and biopharmaceutical development pipeline. Bhartia's expertise is crucial for maintaining investor confidence and securing capital for research and development initiatives. By providing critical financial insights, Sanjay Bhartia enables informed strategic decision-making that underpins Jubilant Pharmova's long-term sustainability and market competitiveness.
Arul Ramakrishnan - Chief Operating Officer
Arul Ramakrishnan, the Chief Operating Officer at Jubilant Pharmova, directs the company's operational strategies and execution. Overseeing day-to-day activities, Ramakrishnan ensures efficient production and supply chain management, critical for delivering patient-focused biopharmaceutical solutions. This leadership role involves optimizing manufacturing processes and maintaining high standards of quality control across all operational facets. Ramakrishnan's focus extends to enhancing operational scalability to meet growing market demands and supporting the company's expansion initiatives. By driving operational excellence, Arul Ramakrishnan directly contributes to the company's ability to bring vital medicines to market and solidify its position in the pharmaceutical industry.
Ward Barney - Chief Operating Officer Cadista
Ward Barney, the Chief Operating Officer Cadista at Jubilant Pharmova, spearheads operational management specifically for the Cadista division. Barney directs the manufacturing, quality assurance, and supply chain functions within this segment, ensuring seamless product delivery. This leadership position focuses on optimizing Cadista's operational efficiency and expanding its market reach. Barney's responsibilities include implementing best practices in production and logistics to meet stringent regulatory requirements and customer expectations. Through dedicated oversight, Ward Barney drives the operational success of Cadista, reinforcing Jubilant Pharmova's commitment to providing high-quality pharmaceutical products.
Harish Vinekar - President Adhesives and Speciality Chemicals
Harish Vinekar, the President Adhesives and Speciality Chemicals at Jubilant Pharmova, leads the strategic direction and operational execution for this business segment. Vinekar oversees product development, market expansion, and sales initiatives within the adhesives and specialty chemicals domain. This leadership position is critical for driving innovation and ensuring the competitive positioning of these product lines. Vinekar's focus includes enhancing customer relationships and exploring new market opportunities to foster growth. By managing these specialized operations, Harish Vinekar contributes significantly to Jubilant Pharmova's diversified portfolio and its overall market presence.
Ved Khare - President, Intl Business
Ved Khare, the President, Intl Business at Jubilant Pharmova, directs the company's global expansion and market penetration strategies. Khare oversees international sales, distribution networks, and regulatory compliance across various global markets. This role is instrumental in extending the reach of Jubilant Pharmova's patient-focused biopharmaceutical solutions worldwide. Khare's responsibilities include identifying new international growth opportunities and forging strategic partnerships to enhance global market share. By leading international operations, Ved Khare ensures that Jubilant Pharmova effectively serves diverse patient populations and strengthens its position as a global healthcare provider.
Alexandra Chambers - Supervisor I, Chief Marketing Officer Training
Alexandra Chambers, the Supervisor I, Chief Marketing Officer Training at Jubilant Pharmova, oversees critical training initiatives for marketing leadership. Chambers develops and implements comprehensive training programs designed to enhance the strategic marketing capabilities of the company's marketing executives. This role focuses on equipping future marketing leaders with the skills necessary to drive brand growth and market penetration in the biopharmaceutical sector. Chambers' work involves curriculum development, performance assessment, and ensuring alignment with evolving market trends and company objectives. By fostering marketing talent, Alexandra Chambers contributes to Jubilant Pharmova's ability to effectively communicate its patient-focused mission and innovative solutions.
Shantanu Jha - Group Chief Human Resources Officer
Shantanu Jha, the Group Chief Human Resources Officer at Jubilant Pharmova, directs the company's comprehensive human capital strategy. Jha oversees talent acquisition, development, and retention programs, fostering a culture that supports innovation and patient focus. This leadership role is essential for building a high-performing workforce capable of driving the company's biopharmaceutical advancements. Jha's responsibilities include developing employee engagement initiatives and ensuring robust HR policies that align with global best practices. By cultivating a skilled and motivated team, Shantanu Jha plays a vital part in Jubilant Pharmova's sustained success and its mission to improve global health outcomes.
Explore Leadership Teams in Manufacturing
Founded in 195 and headquartered in Paris, France, Pierre Fabre is a private pharmaceuticals and dermo-cosmetics company. The company is structured around two divisions: Pharmaceuticals (prescription drugs, consumer health care) and Dermo-cosmetics (including the Europe and Asia market-leader brand Eau Thermale Avène).
Company Leadership AH
ET
YD
Ad
Founded in 1945 and headquartered in Mandaluyong, Philippines Unilab is a manufacturer of pharmaceuticals and other similar products.
Company Leadership SB
RG
MM
JI
Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence worldwide. The companys product candidates focus on treating opioid use disorder, alcohol use disorder, overdose rescue, and CNS disorders/schizophrenia. It markets and promotes SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy analgesic products that include Temgesic, Burpex, and Buprenex. The company was incorporated in 2014 and is headquartered in Richmond,...
Company Leadership
JB
AskBio, is a fully integrated molecular medicine and technology company with operations around the globe. AskBio remains dedicated to the advancement of transformative gene therapeutics, pioneering research and development, groundbreaking synthetic biology, and scalable cGMP manufacturing. Its robust pipeline includes gene therapy candidates at various clinical stages for neuromuscular, central nervous system, metabolic, and cardiovascular diseases. AskBio also has a portfolio of over 775 molecular and genetic medicine patents and an expansive library of capsids and promoters. Global headquarters are in RTP, NC, and European headquarters in Edinburgh. AskBios AAV research centers are in Philadelphia, PA; Columbus, OH; and Paris. Modern clinical, commercial, and synthetic DNA manufacturing facilities are in San Sebastian, Spain. AskBio is a wholly owned, independently operated subsidiary of Bayer.
Company Leadership
CC
JK